# Delivery Order #SPE2DR26FJPN0

Xolair Syringe Delivery Order for DMS Pharmaceutical Group

**Buyer:** Defense Logistics Agency

**Award Amount:** $12,696.24
**Ceiling:** $12,696.24

**Awarded:** June 29, 2026
**Period of Performance:** Jun 29, 2026 - Jul 21, 2026

**Identifier:** SPE2DR26FJPN0
**NAICS:** 424210

This delivery order under DMS Pharmaceutical Group Inc.’s long-term pharmaceutical supply contract procures Xolair (omalizumab), a 300 mg/2 mL prefilled syringe. DMS is a pharmaceutical supplier supporting government healthcare needs. The order covers delivery of the specified medication to Park Ridge, Illinois; the available record does not describe additional services or quantities. This procurement supports access to a specialized medicine, though the data does not specify its intended patient population or broader agency impact. The parent contract runs over a multi-year period, with this order covering a short delivery period. The record does not identify whether the order was competed or sole-source, a contract vehicle or acquisition program, subcontractors, prior related orders, or an original solicitation.

### Description

4572337066!XOLAIR 300 MG/2 ML SYRINGE 2ML

[View original record](https://www.usaspending.gov/award/CONT_AWD_SPE2DR26FJPN0_9700_SPE2DR25D9226_9700)
